nan
Artificial Intelligence (AI) In Warehousing Market Size Outlook: How Fast Will Revenue Grow Through 2030?
The troponin I test kit market size has experienced strong growth in recent years. It is projected to expand from $2.95 billion in 2025 to $3.22 billion in 2026, representing a compound annual growth rate (CAGR) of 9.2%. This growth observed in the past period can be attributed to a rising global prevalence of cardiovascular diseases, increased hospital adoption of rapid cardiac biomarker testing, an expansion of emergency care and critical care infrastructure, growing awareness for early myocardial infarction diagnosis, and the increasing availability of point-of-care diagnostic devices.
The troponin I test kit market is projected to experience substantial expansion in the coming years. Its valuation is set to reach $4.52 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.8%. This anticipated growth during the forecast period stems from several factors, including the proliferation of AI-enabled diagnostic decision support systems, a heightened need for highly sensitive cardiac biomarkers, the rise of decentralized and home-based diagnostic testing, increased healthcare spending on emergency cardiac care infrastructure, and the growing integration of automated laboratory diagnostic platforms. Significant trends identified for this period encompass high-sensitivity point-of-care troponin testing for swift emergency diagnosis, the incorporation of AI-assisted cardiac biomarker interpretation into diagnostic procedures, the creation of ultra-rapid immunoassay-based portable troponin test kits, the broadening of multi-biomarker cardiac panel testing to enhance risk stratification, and the increasing utilization of automated chemiluminescence-based troponin testing platforms.
Download A Free Sample Report For Comprehensive Market Insights:
Troponin I Test Kit Market Expansion Drivers: What Is Shaping Future Growth?
The worldwide rise in the occurrence of cardiovascular disease is anticipated to boost the expansion of the troponin I test kit market in the future. Cardiovascular disease encompasses various conditions impacting the heart and blood vessels, such as coronary artery disease, heart failure, stroke, and myocardial infarction. The increase in cardiovascular disease prevalence stems from expanding aging populations, which elevates the likelihood of cardiac ailments and long-term health issues. Troponin I test kits contribute to addressing global cardiovascular disease prevalence by facilitating the quick and precise identification of cardiac muscle damage, thereby assisting healthcare providers in the early diagnosis and management of acute heart conditions. For example, as reported in September 2025 by the Heart Failure Society of America, a professional organization based in the US, cardiovascular disease was responsible for 919,032 fatalities in the United States in 2023, showing an increase of almost 1.2% compared to the preceding year. Consequently, the expanding global prevalence of cardiovascular disease is stimulating the growth of the troponin I test kit market.
Artificial Intelligence (AI) In Warehousing Market Segment Landscape: Which Areas Lead Market Development?
The troponin i test kit market covered in this report is segmented –
1) By Product Type: Rapid Test Kits; Enzyme Linked Immunosorbent Assay Test Kits; Chemiluminescence Immunoassay Kits; Fluorescence Immunoassay Kits; High Sensitivity Troponin Test Kits
2) By Sample Type: Whole Blood; Serum; Plasma
3) By Application: Acute Myocardial Infarction Diagnosis; Myocardial Injury Detection; Heart Failure Assessment; Risk Stratification Of Patients
4) By End User: Hospitals; Ambulatory Care Centers; Diagnostic Laboratories; Emergency Departments; Clinics; Cardiology Clinics
Subsegments:
1) By Rapid Test Kits: Lateral Flow Assays; Point Of Care Rapid Tests; Cassette Based Tests; Immunochromatographic Assays; Bedside Cardiac Tests
2) By Enzyme Linked Immunosorbent Assay Test Kits: Sandwich Enzyme Linked Immunosorbent Assay Test Kits; Competitive Enzyme Linked Immunosorbent Assay Test Kits; Quantitative Enzyme Linked Immunosorbent Assay Test Kits; Colorimetric Enzyme Linked Immunosorbent Assay Test Kits; High Sensitivity Enzyme Linked Immunosorbent Assay Test Kits
3) By Chemiluminescence Immunoassay Kits: Automated Chemiluminescence Immunoassay Test Kits; Magnetic Particle Chemiluminescence Immunoassay Kits; High Throughput Chemiluminescence Immunoassay Systems; Quantitative Chemiluminescence Immunoassay Assays; Laboratory Based Chemiluminescence Immunoassay Test Kits
4) By Fluorescence Immunoassay Kits: Quantitative Fluorescence Immunoassay Test Kits; Portable Fluorescence Immunoassay Analyzer Kits; Dry Fluorescence Immunoassay Test Kits; Automated Fluorescence Immunoassay Systems; Point Of Care Fluorescence Immunoassay Test Kits
5) By High Sensitivity Troponin Test Kits: High Sensitivity Cardiac Troponin I Laboratory Test Kits; Ultra Sensitive Immunoassay Troponin I Kits; Emergency Cardiac Screening Troponin I Test Kits; Acute Myocardial Infarction Detection Test Kits; Precision Cardiac Biomarker Detection Assays
High-Sensitivity Assay Development Improves Early Cardiac Diagnosis And Laboratory Efficiency
Major companies operating in the troponin I test kit market are focusing on developing advanced solutions, such as high-sensitivity immunoassay manufacturing platforms, to improve analytical precision, accelerate emergency diagnosis workflows, and support earlier detection of myocardial injury. High-sensitivity immunoassay manufacturing platforms refer to advanced diagnostic production systems that enable the detection of extremely low concentrations of cardiac troponin with enhanced assay sensitivity, reproducibility, and rapid turnaround time for clinical laboratories and point-of-care settings. For instance, in October 2024, Siemens Healthineers AG, a Germany-based medical technology company, expanded the clinical application of its Atellica IM High-Sensitivity Troponin I test for advanced cardiovascular risk assessment and emergency diagnostics. The assay provides 10-minute time-to-first-result capability, supports prediction of major adverse cardiac events for up to one year, and delivers highly sensitive cardiac biomarker detection for emergency department workflows.
Troponin I Test Kit Market Competitive Landscape: Who Are The Leading Companies?
Major companies operating in the troponin i test kit market are Abbott Laboratories; F. Hoffmann-La Roche Ltd.; Siemens Healthineers AG; QuidelOrtho; bioMérieux SA; Beckman Coulter; Bio-Rad Laboratories; Randox Laboratories Ltd.; Sekisui Diagnostics LLC; SD BIOSENSOR Inc.; Getein Biotech Inc.; Boditech Med Inc.; YHLO Biotech Co. Ltd.; EDAN Instruments Inc.; Trivitron Healthcare; Sugentech Inc.; Assure Tech (Hangzhou) Co. Ltd.; InTec Products Inc.; Jant Pharmacal Corporation.; Guangzhou Wondfo Biotech Co. Ltd.
Access The Complete Troponin I Test Kit Market Report:
Troponin I Test Kit Market Global Footprint: Which Region Holds Market Leadership?
North America was the largest region in the troponin I test kit market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the troponin i test kit market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.